United Health Products Q2 2026: Cash Drops to $24K, Going Concern Warning Reiterated
UEEC sits 32% above its 52-week low of $0.033.
Summary
United Health Products' Q2 2026 filing shows a critically low cash balance of $24,495, a going concern warning, ineffective disclosure controls, and a restatement of prior financials. The company continues to fund operations through dilutive equity sales.
Key Events · Earnings and Guidance · UEEC
-
Cash Balance Plummets to $24,495
Cash and cash equivalents fell from $65,249 at December 31, 2025 to $24,495 at June 30, 2026, a 62% decline, while the company generated zero revenue.
-
Going Concern Warning Reiterated
Management states there is substantial doubt about the company's ability to continue as a going concern, citing recurring losses, negative working capital of $4,123,570, and insufficient revenue to cover operating expenses.
-
Disclosure Controls Not Effective
The CEO and Principal Financial Officer concluded that the company's disclosure controls and procedures were not effective as of June 30, 2026.
-
Prior Financials Restated
The company identified $108,521 in unrecorded vendor invoices from 2024 and 2025, leading to a restatement of prior-period financial statements. The errors were deemed immaterial individually but material in aggregate.
Analysis · UEEC · Industrial Applications And Services
The company's cash position has deteriorated to just $24,495, down from $65,249 at year-end, while it continues to burn cash with zero revenue. Management reiterates substantial doubt about its ability to continue as a going concern, and the filing reveals ineffective disclosure controls plus a restatement of prior financials for unrecorded vendor invoices. The company is relying on dilutive equity sales to Alumni Capital to stay afloat, with 1.1 million shares issued after quarter-end for only $44,946.
At the time of this filing, UEEC was trading at $0.04 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $11.5M. The 52-week trading range was $0.03 to $0.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.